Cancer Vaccine Week articles

Recent articles from Cancer Vaccine Week

Data on cancer vaccines published by researchers at National Cancer Institute.
June 22, 2009... "The tumor-associated Tn antigen has been investigated extensively as a biomarker and therapeutic target. Cancer vaccines containing the Tin antigen as a single tumor antigen or as a component of a polyvalent vaccine have progressed into phase I and II clinical trials," scientists in the...

New cancer vaccines study findings recently were published by researchers at University of California.
June 22, 2009... According to a study from the United States, "Whereas chemotherapy is the standard of care for metastatic castration-resistant prostate cancer and is associated with a survival benefit, there remains a need for alternative approaches. Extensive work has been done evaluating multiple...

New findings in cancer vaccines described by J. Zeng and co-researchers.
June 22, 2009... According to a study from Guangzhou, People's Republic of China, "The present study investigated an immunotherapeutic strategy for rearranged during transfection proto-oncogene (ret)associated carcinomas in a transgenic MT/ret 304/B6 mouse model in which spontaneous tumors develop due to...

Study results from L. Annemans and colleagues in the area of cancer vaccines published.
June 22, 2009... According to recent research from Lyon, France, "The introduction of a quadrivalent human papillomavirus (HPV; types 6, 11, 16, 18) vaccine is expected to significantly reduce the burden of cervical cancer, cervical intraepithelial neoplasia (CIN), genital warts and other HPV-related...

Study results from McMaster University update understanding of cancer vaccines.
June 22, 2009... According to recent research from Hamilton, Canada, "Tumors that recur following surgical resection of melanoma are typically metastatic and associated with poor prognosis. Using the murine B16F10 melanoma and a robust antimelanoma vaccine, we evaluated immunization as a tool to improve...